2025-07-29 - Analysis Report
Okay, here's a comprehensive analysis of Teladoc Health Inc (TDOC) based on the provided data.

## Teladoc Health Inc (TDOC) Analysis

**Company Overview:** Teladoc Health Inc is a telehealth company offering virtual healthcare services.

### 1. Performance vs. S&P 500 (VOO)

**Key Numbers:**

*   **TDOC Cumulative Return:** -64.52%
*   **VOO Cumulative Return:** 100.71%
*   **Absolute Divergence (Current):** -165.23%
*   **Divergence Range (Max: 456.6, Min: -165.3):**
*   **Relative Divergence:** 0.0

**Analysis:**

TDOC has significantly underperformed the S&P 500 (VOO) over the period. The -165.3% absolute divergence highlights this stark difference. The relative divergence of 0.0 indicates that the current divergence is at the lowest end of its historical range, suggesting the underperformance is as severe as it has been historically based on the data provided.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta   | Cap(B) |
|------------|---------|-------|---------|--------|--------|
| 2015-2017  | 76.0%  | 60.6% | 50.0%  | -0.0   | 6.1    |
| 2016-2018  | 128.0% | 59.3% | 110.0% | -0.0   | 8.7    |
| 2017-2019  | 176.0% | 59.3% | 147.0% | 0.4    | 14.7   |
| 2018-2020  | 237.0% | 64.0% | 217.0% | 0.1    | 35.1   |
| 2019-2021  | -83.0% | 64.0% | -132.0% | 0.1    | 16.1   |
| 2020-2022  | -295.0% | 81.3% | -297.0% | 0.0    | 4.2    |
| 2021-2023  | -488.0% | 81.3% | -506.0% | -0.6   | 3.8    |
| 2022-2024  | -111.0% | 81.3% | -137.0% | -0.8   | 1.6    |
| 2023-2025  | -35.0%  | 72.9% | -87.0%  | -0.8   | 1.4    |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows significant growth in the early periods (2015-2020), but it has turned sharply negative in recent years (2019-2025). This indicates a severe downturn in performance.
*   **MDD:** The Maximum Drawdown (MDD) is consistently high, ranging from around 60% to over 80%. This signifies that the stock has experienced substantial peak-to-trough declines.
*   **Alpha:** Alpha measures the excess return compared to a benchmark. The positive alphas in earlier periods (2015-2020) indicate that TDOC was outperforming its benchmark, but the negative alphas in recent years (2019-2025) show significant underperformance.
*   **Beta:** Beta measures the stock's volatility relative to the market. The betas are mostly near zero or negative, which suggests that TDOC's price movements are not strongly correlated with the overall market. In the later years, the negative betas (-0.6 to -0.8) suggest an inverse relationship with the market, meaning it may move in the opposite direction of the market.
*   **Cap(B):** The market capitalization has declined significantly from a high of $35.1 billion (2018-2020) to a low of $1.4 billion (2023-2025), reflecting a substantial loss in investor confidence and market value.

### 2. Recent Stock Price Movements

**Key Numbers:**

*   **Current Price:** \$8.20
*   **Previous Close:** \$8.20
*   **Change:** \$0.00
*   **5-Day Moving Average:** \$8.32
*   **20-Day Moving Average:** \$8.327
*   **60-Day Moving Average:** \$7.589

**Analysis:**

The current price is virtually unchanged from the previous close, indicating stability in the very short term. The 5-day and 20-day moving averages are slightly above the current price, suggesting a possible slight downward trend in the short term. The 60-day moving average is lower than the current price, which could indicate a recent upward movement relative to the past two months.

### 3. Technical Indicators

**Key Numbers:**

*   **Market Risk Indicator (MRI):** 0.3286 (Low Risk)
*   **RSI:** 43.51
*   **PPO:** -0.58
*   **Hybrid Signal:** cash_69%_Sell 1.0% of holdings (16 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Divergence Change:** 0.0 (-) : 단기하락
*   **Expected Return (%):** -9793.2

**Analysis:**

*   **MRI:** A low-risk MRI suggests that, based on the metrics used to calculate it, the stock is not considered highly risky at the moment.
*   **RSI:** An RSI of 43.51 indicates that the stock is neither overbought nor oversold.
*   **PPO:** A PPO of -0.58 suggests the stock is slightly below its moving average, hinting at a possible short-term downtrend.
*   **Hybrid Signal:** The hybrid signal recommends a cautious approach, advising to hold a high cash position (69%) and sell a small percentage (1%) of holdings, equivalent to 16 shares. This suggests that the system is bearish on the stock.
*   **Recent (20-day) Relative Divergence Change:** 0.0 (-): 단기하락: This indicates a short-term decline in relative performance.
*   **Expected Return (%):** -9793.2:  This extremely negative expected return suggests that, based on the models used, long-term investment in TDOC is predicted to significantly underperform the S&P 500. This figure should be viewed with caution, as such extreme predictions are often unreliable.
*   **Last-market:** {'price': 8.2, 'previousClose': 8.2, 'change': 0.0}: The change is 0.0 which mean there is no issue from this.

### 4. Recent News & Significant Events

*   **[2025-07-29]:** Teladoc Health Inc (TDOC) has recently made headlines due to major business developments, regulatory changes, or market events.
*   **[2025-07-25]:** Analysts are discussing Teladoc Health Inc's (TDOC) recent performance and its outlook in the context of industry trends and global economic factors.
*   **[2025-07-28]:** Teladoc Health Inc (TDOC)'s stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-26]:** Market experts highlight both risks and opportunities for Teladoc Health Inc (TDOC), advising investors to monitor recent news and company announcements.

**Analysis:**

The news snippets suggest that TDOC is experiencing notable volatility and is subject to scrutiny from analysts due to recent performance. The market advises caution and monitoring of company announcements.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-05-01 | -0.53 | 0.63 B$   |
| 2024-10-31 | -0.19 | 0.64 B$   |
| 2024-08-01 | -4.92 | 0.64 B$   |
| 2024-04-26 | -0.49 | 0.65 B$   |
| 2025-05-01 | -0.49 | 0.65 B$   |

**Analysis:**

The Earnings Per Share (EPS) figures are consistently negative, indicating a lack of profitability. While revenue has been relatively stable around $0.63-0.65 billion, the company has not been able to convert this revenue into positive earnings. The large negative EPS in 2024-08-01 suggests a significant loss during that quarter. Duplicated data in 2025-05-01

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $0.63B    | 68.73%        |
| 2024-12-31   | $0.64B    | 70.50%        |
| 2024-09-30   | $0.64B    | 71.94%        |
| 2024-06-30   | $0.64B    | 70.73%        |
| 2024-03-31   | $0.65B    | 69.89%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE      |
|--------------|-----------|----------|
| 2025-03-31   | $1.43B    | -6.52%   |
| 2024-12-31   | $1.49B    | -3.25%   |
| 2024-09-30   | $1.51B    | -2.21%   |
| 2024-06-30   | $1.50B    | -55.77%  |
| 2024-03-31   | $2.29B    | -3.58%   |

**Analysis:**

*   **Revenue and Profitability:** Revenue has remained relatively stable over the past five quarters. The profit margin is consistently high, ranging from 68.73% to 71.94%, which is a positive sign.
*   **Capital and Profitability:** Equity has decreased significantly from $2.29B in 2024-03-31 to $1.43B in 2025-03-31, indicating a decline in the company's net worth. The Return on Equity (ROE) is consistently negative, which means the company is not generating profits from shareholders' investments. The -55.77% ROE in 2024-06-30 is particularly alarming.

### 7. Overall Summary

Teladoc Health Inc (TDOC) is currently facing significant challenges. While revenue and profit margins have been relatively stable, the company's stock has underperformed significantly compared to the S&P 500. Recent earnings have been negative, and equity has declined, leading to negative returns on equity. Technical indicators and news suggest caution.
